BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3800328)

  • 1. DNA-grading of malignant lymphomas. II. Correlation with clinical parameters.
    Böcking A; Chatelain R; Auffermann W; Löhr GW; Reif M; Rossner R; Becker H
    Anticancer Res; 1986; 6(5):1217-23. PubMed ID: 3800328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-grading of malignant lymphomas. I. Prognostic significance, reproducibility and comparison with other classifications.
    Böcking A; Chatelain R; Auffermann W; Krüger GR; Asmus B; Wohltmann D; Schuster C
    Anticancer Res; 1986; 6(5):1205-16. PubMed ID: 3800327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study of the non-Hodgkin's lymphomas according to the Kiel classification (author's transl)].
    Stacher A; Heinz R; Waldner R
    Arch Geschwulstforsch; 1979; 49(8):715-30. PubMed ID: 120730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
    Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
    J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
    Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
    Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant non-Hodgkin's lymphoma of the joint. Report of two cases, review of the literature and problems of classification].
    Krüger R; Oden J; de Leon F; Dürr W
    Unfallchirurg; 1993 Oct; 96(10):556-62. PubMed ID: 8235678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
    Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
    Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survival of patients and DNA-ploidy of cells in non-Hodgkin's lymphoma of low-grade malignancy].
    Urasiński I; Urasiński T; Krygier-Stojałowska A
    Acta Haematol Pol; 1994; 25(4):355-61. PubMed ID: 7847037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
    Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of malignant lymphomas].
    Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
    Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
    Smaaland R; Lote K; Sothern RB; Laerum OD
    Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
    Rasmuson T; Björk GR
    Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA--ploidy in non hodgkin's lymphomas of low malignancy].
    Krygier-Stojałowska A; Urasiński I; Kuchnio M; Gapski Z
    Acta Haematol Pol; 1993; 24(2):153-60. PubMed ID: 8372615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of high grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
    Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
    Pol J Pathol; 1994; 45(4):271-4. PubMed ID: 7697328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-Hodgkin lymphomas. New histological, cytological and prognostic correlations (author's transl)].
    Hérait P; Gérard-Marchant R; Amiel JL; Caillaud JM; Tursz T; Droz JP
    Nouv Presse Med; 1981 Jun; 10(27):2267-71. PubMed ID: 7022369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and significance of chromosome abnormalities in patients with malignant non-Hodgkin's lymphoma using the polymerase chain reaction].
    Janda J; Benesová E; Slavícková A; Klener P
    Cas Lek Cesk; 1999 Jan; 138(2):47-51. PubMed ID: 10376403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.